Hypometabolism in the limbic system of cancer patients observed by positron emission tomography
✍ Scribed by Manabu Tashiro; Kazuo Kubota; Masatoshi Itoh; Takashi Yoshioka; Masayuki Yoshida; Yoichi Nakagawa; Daniel Bereczki; Hidetada Sasaki
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 105 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1057-9249
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m
## Abstract ## Objective Erdheim‐Chester disease (ECD) is a rare form of non–Langerhans' cell histiocytosis. The aim of this study was to assess the value of whole‐body scanning with ^18^F‐fluorodeoxyglucose–positron emission tomography (FDG‐PET) in a large cohort of ECD patients from a single cen
## Objective: The 2-[(18)f]-fluoro-2-deoxy-d-glucose-positron emission tomography (fdg-pet) technique provides information on uptake and metabolism of glucose in various tissues. compared with resting cells, activated lymphocytes take up radioactively labeled glucose analog at a higher rate, which